Table 3. Clinical course and outcome between ESB patients and Non-bleeding patients.
Variable | ESB Group (n = 24) | Non-bleeding Group (n = 24) | P Value |
---|---|---|---|
IPN, no. (%) | 19 (79.2) | 15 (62.5) | NS (0.204) |
Digestive tract fistula, no. (%) | 10 (41.7) | 6 (25.0) | NS (0.221) |
SVT, no. (%) | 5 (20.8) | 5 (20.8) | NS (1) |
ACS, no. (%) | 7 (29.2) | 0 (0) | 0.004 |
Organ failure | |||
Shock, no. (%) | 16 (66.7) | 8 (33.3) | 0.021 |
ARDS, no. (%) | 19 (79.2) | 15 (62.5) | NS (0.204) |
AKI, no. (%) | 17 (70.8) | 10 (41.6) | 0.042 |
ALI, no. (%) | 13 (54.2) | 6 (25.0) | 0.039 |
MODS, no. (%) | 18 (75.0) | 8 (33.3) | 0.004 |
Management | |||
CRRT, no. (%) | 16 (66.7) | 8 (33.3) | 0.021 |
PCD, no. (%) | 20 (83.3) | 13 (54.2) | 0.029 |
NPI, no. (%) | 18 (75.0) | 8 (33.3) | 0.004 |
ED, no. (%) | 11 (45.8) | 8 (33.3) | NS (0.376) |
DSA, no. (%) | 17 (70.8) | 5 (20.8) | 0.001 |
Laparotomy, no. (%) | 12 (50.0) | 6 (25.0) | NS (0.074) |
Revised Atlanta classification | 0.001 | ||
Mild, no. (%) | 0 (0) | 0 (0) | |
Moderate severe, no. (%) | 2 (8.3) | 13 (54.2) | |
Severe, no. (%) | 22 (91.7) | 11 (45.8) | |
Mortality, no. (%) | 13 (54.2) | 5 (20.8) | 0.017 |
Hospital duration, days | 35 (19.5–83.75) | 13.5 (8–64.5) | NS (0.060) |
ICU duration, days | 24.5 (12.75–46.25) | 9 (4.25–33.75) | 0.042 |
Cost, thousand CNY | 293 (183–459) | 120 (49–449) | 0.026 |
IPN infected pancreatic necrosis, SVT splanchnic venous thrombosis, ACS abdominal compartment syndrome, ARDS acute respiratory distress syndrome, AKI acute kidney injury, ALI acute liver injury, MODS multiple organ dysfunction syndrome, CRRT continuous renal replacement therapy, PCD percutaneous catheter drainage, NPI negative pressure irrigation, ED endoscopic necrosectomy, DSA digital subtraction angiography, ICU intensive care unit. Data are expressed as median (interquartile range) for continuous variables and frequencies (proportions) for categorical variables, as appropriate. Mann–Whitney U-test and Pearson test was used as the circumstances required.